148 related articles for article (PubMed ID: 31757836)
21. The
Li Z; Wu M; Zhao H; Fan L; Zhang Y; Yuan T; He S; Wang P; Zhang Y; Sun X; Wang S
Anim Biotechnol; 2020 Dec; 31(6):504-511. PubMed ID: 31253059
[TBL] [Abstract][Full Text] [Related]
22. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II.
Voz ML; Agten NS; Van de Ven WJ; Kas K
Cancer Res; 2000 Jan; 60(1):106-13. PubMed ID: 10646861
[TBL] [Abstract][Full Text] [Related]
23. Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma.
Yu C; Li J; Sun F; Cui J; Fang H; Sui G
Med Sci Monit; 2016 Dec; 22():5101-5108. PubMed ID: 28012286
[TBL] [Abstract][Full Text] [Related]
24. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.
Olanich ME; Sun W; Hewitt SM; Abdullaev Z; Pack SD; Barr FG
Clin Cancer Res; 2015 Nov; 21(21):4947-59. PubMed ID: 25810375
[TBL] [Abstract][Full Text] [Related]
25. Opposing functions of PLAG1 in pleomorphic adenoma: a microarray analysis of PLAG1 transgenic mice.
Wang Y; Shang W; Lei X; Shen S; Zhang H; Wang Z; Huang L; Yu Z; Ong H; Yin X; Yang W; Zhang C
Biotechnol Lett; 2013 Sep; 35(9):1377-85. PubMed ID: 23690029
[TBL] [Abstract][Full Text] [Related]
26. Differential mechanisms of acquired resistance to insulin-like growth factor-i receptor antibody therapy or to a small-molecule inhibitor, BMS-754807, in a human rhabdomyosarcoma model.
Huang F; Hurlburt W; Greer A; Reeves KA; Hillerman S; Chang H; Fargnoli J; Graf Finckenstein F; Gottardis MM; Carboni JM
Cancer Res; 2010 Sep; 70(18):7221-31. PubMed ID: 20807811
[TBL] [Abstract][Full Text] [Related]
27. Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.
Slemmons KK; Crose LE; Rudzinski E; Bentley RC; Linardic CM
PLoS One; 2015; 10(10):e0140781. PubMed ID: 26496700
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S
Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674
[TBL] [Abstract][Full Text] [Related]
29. aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice.
Van Dyck F; Scroyen I; Declercq J; Sciot R; Kahn B; Lijnen R; Van de Ven WJ
Int J Oncol; 2008 Jan; 32(1):33-40. PubMed ID: 18097540
[TBL] [Abstract][Full Text] [Related]
30. Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis.
De Giovanni C; Nanni P; Landuzzi L; Ianzano ML; Nicoletti G; Croci S; Palladini A; Lollini PL
BMC Cancer; 2019 Feb; 19(1):126. PubMed ID: 30732578
[TBL] [Abstract][Full Text] [Related]
31. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.
Ciccarelli C; Vulcano F; Milazzo L; Gravina GL; Marampon F; Macioce G; Giampaolo A; Tombolini V; Di Paolo V; Hassan HJ; Zani BM
Mol Cancer; 2016 Feb; 15():16. PubMed ID: 26897742
[TBL] [Abstract][Full Text] [Related]
32. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
Taylor AC; Schuster K; McKenzie PP; Harris LC
Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
[TBL] [Abstract][Full Text] [Related]
33. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression.
Declercq J; Van Dyck F; Braem CV; Van Valckenborgh IC; Voz M; Wassef M; Schoonjans L; Van Damme B; Fiette L; Van de Ven WJ
Cancer Res; 2005 Jun; 65(11):4544-53. PubMed ID: 15930271
[TBL] [Abstract][Full Text] [Related]
34. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
Basma H; Ghayad SE; Rammal G; Mancinelli A; Harajly M; Ghamloush F; Dweik L; El-Eit R; Zalzali H; Rabeh W; Pisano C; Darwiche N; Saab R
Int J Cancer; 2016 Mar; 138(6):1528-37. PubMed ID: 26453552
[TBL] [Abstract][Full Text] [Related]
35. 5‑Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin‑like growth factor 2 expression and reactivating the H19 gene product miR‑675, which negatively affects insulin‑like growth factors and insulin signaling.
Tarnowski M; Tkacz M; Czerewaty M; Poniewierska-Baran A; Grymuła K; Ratajczak MZ
Int J Oncol; 2015 May; 46(5):2241-50. PubMed ID: 25707431
[TBL] [Abstract][Full Text] [Related]
36. Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression.
Declercq J; Skaland I; Van Dyck F; Janssen EA; Baak JP; Drijkoningen M; Van de Ven WJ
Int J Cancer; 2008 Oct; 123(7):1593-600. PubMed ID: 18649356
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma.
Sun MM; Li JF; Guo LL; Xiao HT; Dong L; Wang F; Huang FB; Cao D; Qin T; Yin XH; Li JM; Wang SL
Oncogene; 2014 Apr; 33(16):2075-86. PubMed ID: 23665678
[TBL] [Abstract][Full Text] [Related]
38. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S
Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.
Fu P; Thompson JA; Leeding KS; Bach LA
J Cell Biochem; 2007 Jan; 100(1):58-68. PubMed ID: 16888814
[TBL] [Abstract][Full Text] [Related]
40. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.
Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H
Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
